Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00001551
Other study ID # 960088
Secondary ID 96-N-0088
Status Completed
Phase N/A
First received November 3, 1999
Last updated June 30, 2017
Start date May 22, 1996

Study information

Verified date November 13, 2009
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

According to studies, speech disorders with unknown causes (idiopathic) affect approximately 5% of the population at some point in their life. Some of these disorders like, stuttering and cluttering, are known for being detected early, during speech development.

Stuttering is characterized by sound and syllable repetitions and consonant/vowel prolongations. When stuttering is moderate to severe, it can interfere with a person's job and social activities.

Speech articulation disorders are characterized by omissions, or substitutions of speech sounds. The speech of a person who clutters is often difficult to understand. People are often unaware of the errors they make when speaking causing treatment of the condition to be very difficult.

The purpose of this research is to study an extended family whose members exhibit a pure form of speech articulation disorders

In addition, the study will use data and information gathered from the study and use it to develop guidelines (criteria) for defining and differentiating patients with speech disorders.


Description:

Objective:

Our objective is to determine which factors are involved in the development of stuttering and familial phonological processing disorder and are associated with a familial pattern of inheritance.

Study population: The study population is comprised of 8 groups:

1. Children and adults with persistent developmental stuttering;

2. Unaffected siblings of the individuals affected with developmental stuttering or recovered from stuttering

3. Children and adults who have recovered from developmental stuttering;

4. Children and adults with persistent familial phonological processing disorders (FPPD);

5. Unaffected siblings of the individuals affected with FPPD or have recovered from FPPD

6. Children and adults who have recovered from FPPD;

7. Unaffected siblings of the individuals who have recovered from FPPD;

8. Children and adults with normal speech and language development who will comprise the control groups.

Design: A Natural history design will be used to compare affected and unaffected family members with healthy volunteers with normal speech and language.

Outcome Measures: Genetic markers and pedigree analyses will be used to test familial inheritance patterns. Speech and language development will be compared using indices of speech perception, auditory perception, self monitoring of one's own speech, language complexity, motor complexity, speech learning, phonological processing and verbal/nonverbal memory.


Recruitment information / eligibility

Status Completed
Enrollment 375
Est. completion date
Est. primary completion date November 13, 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility -INCLUSION CRITERIA:

i. Normal Language Development, Hearing and Cognition

ii. The following screening tests previously published with norms were found to have a good distribution for determining normal functioning in adolescents and adults as all subjects did not hit ceiling and all had scores greater than or equal to the 80th percentile. These tests are being used to ensure that subjects affected with stuttering or FPPD do not have other disorders such as hearing loss, language delay, or mental retardation.

Peabody Picture Vocabulary Test III (PPVT-III)

Expressive Vocabulary Test (EVT)

Oral Speech Mechanism Screening Examination

Revised Token Test; Token test for Children

Test of Non verbal intelligence (TONI-2)

Digit Span subtest of the WICS-R

Audiometric Screening

Goldman Fristoe Test of Articulation

WUG Test of Morphological Encoding

Test of Auditory Comprehension of Language (TACL)

Khan-Lewis Phonological Analysis

INCLUSION CRITERIA FOR IDENTIFYING AND QUANTIFYING STUTTERING:

The Stuttering Severity Index -3 (Riley, 1981) has been found to be accurate for identifying and assessing the severity of stuttering during conversational speech. For the inclusion of a stuttering subject we require:

i. A total overall score of 11 or greater between 3 and 17 years,

ii. A total overall score of 18 or greater from age 18 and above.

INCLUSION CRITERIA FOR IDENTIFYING FPPD:

i. A family history of an autosomal dominant pattern of inheritance of the speech disorder over several generations with persistence into adulthood in some cases,

ii. Speech symptoms during conversational speech include: deletion of final consonants; syllable reduction and syllable deletion; deletion of grammatical markers such as copulas, auxiliaries, prepositions, connectives; poor ability to self-correct; poor awareness of errors; and consonant cluster reduction.

iii. Greater than 9% discourse errors during analysis of a sample of 300 syllables.

iv. A discrepancy of 30 points (1 and 1/2 Standard Deviations) between receptive (the higher score) and expressive percentile score on the PPVT III and Expressive Vocabulary Test.

v. For subjects greater than 7 years of age, a phonological process rating of 3 or more for any phonological process on the Khan-Lewis Phonological Analysis. For subjects less than 7 years of age, a phonological process rating of 3 or more on 2 phonological processes on the Khan-Lewis Phonological Analysis. Finally, any subjects with a non developmental phonological process error will be identified as potentially having FPPD.

EXCLUSION CRITERIA:

i. Anyone with a hearing loss will be excluded from participation during the diagnostic testing.

ii. Children with delayed language, more than 1 year delay from norms on receptive and expression language testing will be excluded.

iii. Language impairment: scores more than 2 standard deviations below the age appropriate score on the standardized language tests listed under the inclusion criteria.

iv. Cognitive impairment: scores more than 2 standard deviations below the age appropriate score on the standardized cognitive tests listed under the inclusion criteria.

v. Bilingual non-native English speakers - Studies have demonstrated that brain organization for speech and language may differ in bilingual persons. It is hypothesized that this may alter speech motor learning and thus kinematic data from non-native English speakers would differ from native English speakers. Therefore, only native-American English speakers, with only one language spoken in the home, will be included.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Maryland, College Park College Park Maryland
United States University of Wisconsin Madison Wisconsin

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

References & Publications (3)

Cox NJ, Seider RA, Kidd KK. Some environmental factors and hypotheses for stuttering in families with several stutterers. J Speech Hear Res. 1984 Dec;27(4):543-8. — View Citation

Felsenfeld S, McGue M, Broen PA. Familial aggregation of phonological disorders: results from a 28-year follow-up. J Speech Hear Res. 1995 Oct;38(5):1091-107. — View Citation

Plomin R, Owen MJ, McGuffin P. The genetic basis of complex human behaviors. Science. 1994 Jun 17;264(5166):1733-9. Review. — View Citation

See also
  Status Clinical Trial Phase
Suspended NCT01684657 - A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering Phase 3
Not yet recruiting NCT05437627 - Computerized Based Analysis for Detection and Severity Assessment of Stuttering
Completed NCT02288598 - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering N/A
Completed NCT00001602 - Genetic Factors Related to Stuttering N/A
Active, not recruiting NCT04082104 - Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
Completed NCT04580966 - IBSR Intervention for Adults Who Stutter N/A
Recruiting NCT00148161 - Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering N/A
Recruiting NCT05908123 - Exploring the Nature, Assessment and Treatment of Stuttering N/A
Withdrawn NCT01315730 - The Effects of Tactile Speech Feedback on Stuttering Frequency Phase 1
Completed NCT00004991 - Study of Brain Activity During Speech Production and Speech Perception N/A
Recruiting NCT05286151 - Network Connectivity and Temporal Processing in Adolescents Who Stutter N/A
Completed NCT00001604 - Genetic Linkage Studies of Stuttering
Recruiting NCT00680303 - Spacing Lidcombe Program Clinic Visits Phase 2
Recruiting NCT00709072 - Follow-up of Children After Stuttering Treatment Phase 2
Completed NCT00830154 - A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering Phase 2/Phase 3
Completed NCT03698539 - How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
Completed NCT04505696 - Providing Speech Therapy Awareness in Private Schools N/A
Recruiting NCT04929184 - Speech Processing in Stuttering N/A
Terminated NCT00001308 - Central Mechanisms in Speech Motor Control Studied With H215O PET
Completed NCT01097161 - Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program N/A